The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artesunate Drugs Market Research Report 2025
Synopsis
Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.
The global Artesunate Drugs market was valued at US$ 168 million in 2023 and is anticipated to reach US$ 277.7 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artesunate Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artesunate Drugs.
Report Scope
The Artesunate Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artesunate Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artesunate Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fosun Pharma (Guilin)
Ipca Laboratories
Sanofi Aventis
Ajanta Pharma
Shin Poong
Cipla
Acino
MCW Healthcare
Segment by Type
Monoaromatic Artesunate
Compound Artesunate
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artesunate Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.
The global Artesunate Drugs market was valued at US$ 168 million in 2023 and is anticipated to reach US$ 277.7 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artesunate Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artesunate Drugs.
Report Scope
The Artesunate Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artesunate Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artesunate Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fosun Pharma (Guilin)
Ipca Laboratories
Sanofi Aventis
Ajanta Pharma
Shin Poong
Cipla
Acino
MCW Healthcare
Segment by Type
Monoaromatic Artesunate
Compound Artesunate
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artesunate Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artesunate Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoaromatic Artesunate
1.2.3 Compound Artesunate
1.3 Market by Application
1.3.1 Global Artesunate Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artesunate Drugs Market Perspective (2019-2030)
2.2 Artesunate Drugs Growth Trends by Region
2.2.1 Global Artesunate Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artesunate Drugs Historic Market Size by Region (2019-2024)
2.2.3 Artesunate Drugs Forecasted Market Size by Region (2025-2030)
2.3 Artesunate Drugs Market Dynamics
2.3.1 Artesunate Drugs Industry Trends
2.3.2 Artesunate Drugs Market Drivers
2.3.3 Artesunate Drugs Market Challenges
2.3.4 Artesunate Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artesunate Drugs Players by Revenue
3.1.1 Global Top Artesunate Drugs Players by Revenue (2019-2024)
3.1.2 Global Artesunate Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Artesunate Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artesunate Drugs Revenue
3.4 Global Artesunate Drugs Market Concentration Ratio
3.4.1 Global Artesunate Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artesunate Drugs Revenue in 2023
3.5 Artesunate Drugs Key Players Head office and Area Served
3.6 Key Players Artesunate Drugs Product Solution and Service
3.7 Date of Enter into Artesunate Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artesunate Drugs Breakdown Data by Type
4.1 Global Artesunate Drugs Historic Market Size by Type (2019-2024)
4.2 Global Artesunate Drugs Forecasted Market Size by Type (2025-2030)
5 Artesunate Drugs Breakdown Data by Application
5.1 Global Artesunate Drugs Historic Market Size by Application (2019-2024)
5.2 Global Artesunate Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artesunate Drugs Market Size (2019-2030)
6.2 North America Artesunate Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artesunate Drugs Market Size by Country (2019-2024)
6.4 North America Artesunate Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artesunate Drugs Market Size (2019-2030)
7.2 Europe Artesunate Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artesunate Drugs Market Size by Country (2019-2024)
7.4 Europe Artesunate Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artesunate Drugs Market Size (2019-2030)
8.2 Asia-Pacific Artesunate Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artesunate Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Artesunate Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artesunate Drugs Market Size (2019-2030)
9.2 Latin America Artesunate Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artesunate Drugs Market Size by Country (2019-2024)
9.4 Latin America Artesunate Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artesunate Drugs Market Size (2019-2030)
10.2 Middle East & Africa Artesunate Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artesunate Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Artesunate Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fosun Pharma (Guilin)
11.1.1 Fosun Pharma (Guilin) Company Detail
11.1.2 Fosun Pharma (Guilin) Business Overview
11.1.3 Fosun Pharma (Guilin) Artesunate Drugs Introduction
11.1.4 Fosun Pharma (Guilin) Revenue in Artesunate Drugs Business (2019-2024)
11.1.5 Fosun Pharma (Guilin) Recent Development
11.2 Ipca Laboratories
11.2.1 Ipca Laboratories Company Detail
11.2.2 Ipca Laboratories Business Overview
11.2.3 Ipca Laboratories Artesunate Drugs Introduction
11.2.4 Ipca Laboratories Revenue in Artesunate Drugs Business (2019-2024)
11.2.5 Ipca Laboratories Recent Development
11.3 Sanofi Aventis
11.3.1 Sanofi Aventis Company Detail
11.3.2 Sanofi Aventis Business Overview
11.3.3 Sanofi Aventis Artesunate Drugs Introduction
11.3.4 Sanofi Aventis Revenue in Artesunate Drugs Business (2019-2024)
11.3.5 Sanofi Aventis Recent Development
11.4 Ajanta Pharma
11.4.1 Ajanta Pharma Company Detail
11.4.2 Ajanta Pharma Business Overview
11.4.3 Ajanta Pharma Artesunate Drugs Introduction
11.4.4 Ajanta Pharma Revenue in Artesunate Drugs Business (2019-2024)
11.4.5 Ajanta Pharma Recent Development
11.5 Shin Poong
11.5.1 Shin Poong Company Detail
11.5.2 Shin Poong Business Overview
11.5.3 Shin Poong Artesunate Drugs Introduction
11.5.4 Shin Poong Revenue in Artesunate Drugs Business (2019-2024)
11.5.5 Shin Poong Recent Development
11.6 Cipla
11.6.1 Cipla Company Detail
11.6.2 Cipla Business Overview
11.6.3 Cipla Artesunate Drugs Introduction
11.6.4 Cipla Revenue in Artesunate Drugs Business (2019-2024)
11.6.5 Cipla Recent Development
11.7 Acino
11.7.1 Acino Company Detail
11.7.2 Acino Business Overview
11.7.3 Acino Artesunate Drugs Introduction
11.7.4 Acino Revenue in Artesunate Drugs Business (2019-2024)
11.7.5 Acino Recent Development
11.8 MCW Healthcare
11.8.1 MCW Healthcare Company Detail
11.8.2 MCW Healthcare Business Overview
11.8.3 MCW Healthcare Artesunate Drugs Introduction
11.8.4 MCW Healthcare Revenue in Artesunate Drugs Business (2019-2024)
11.8.5 MCW Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Artesunate Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Monoaromatic Artesunate
Table 3. Key Players of Compound Artesunate
Table 4. Global Artesunate Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Artesunate Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Artesunate Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Artesunate Drugs Market Share by Region (2019-2024)
Table 8. Global Artesunate Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Artesunate Drugs Market Share by Region (2025-2030)
Table 10. Artesunate Drugs Market Trends
Table 11. Artesunate Drugs Market Drivers
Table 12. Artesunate Drugs Market Challenges
Table 13. Artesunate Drugs Market Restraints
Table 14. Global Artesunate Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Artesunate Drugs Market Share by Players (2019-2024)
Table 16. Global Top Artesunate Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artesunate Drugs as of 2023)
Table 17. Ranking of Global Top Artesunate Drugs Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Artesunate Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Artesunate Drugs Product Solution and Service
Table 21. Date of Enter into Artesunate Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Artesunate Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Artesunate Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Artesunate Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Artesunate Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Artesunate Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Artesunate Drugs Revenue Market Share by Application (2019-2024)
Table 29. Global Artesunate Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Artesunate Drugs Revenue Market Share by Application (2025-2030)
Table 31. North America Artesunate Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Artesunate Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Artesunate Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Artesunate Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Artesunate Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Artesunate Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Artesunate Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Artesunate Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Artesunate Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Artesunate Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Artesunate Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Artesunate Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Artesunate Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Artesunate Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Artesunate Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Fosun Pharma (Guilin) Company Detail
Table 47. Fosun Pharma (Guilin) Business Overview
Table 48. Fosun Pharma (Guilin) Artesunate Drugs Product
Table 49. Fosun Pharma (Guilin) Revenue in Artesunate Drugs Business (2019-2024) & (US$ Million)
Table 50. Fosun Pharma (Guilin) Recent Development
Table 51. Ipca Laboratories Company Detail
Table 52. Ipca Laboratories Business Overview
Table 53. Ipca Laboratories Artesunate Drugs Product
Table 54. Ipca Laboratories Revenue in Artesunate Drugs Business (2019-2024) & (US$ Million)
Table 55. Ipca Laboratories Recent Development
Table 56. Sanofi Aventis Company Detail
Table 57. Sanofi Aventis Business Overview
Table 58. Sanofi Aventis Artesunate Drugs Product
Table 59. Sanofi Aventis Revenue in Artesunate Drugs Business (2019-2024) & (US$ Million)
Table 60. Sanofi Aventis Recent Development
Table 61. Ajanta Pharma Company Detail
Table 62. Ajanta Pharma Business Overview
Table 63. Ajanta Pharma Artesunate Drugs Product
Table 64. Ajanta Pharma Revenue in Artesunate Drugs Business (2019-2024) & (US$ Million)
Table 65. Ajanta Pharma Recent Development
Table 66. Shin Poong Company Detail
Table 67. Shin Poong Business Overview
Table 68. Shin Poong Artesunate Drugs Product
Table 69. Shin Poong Revenue in Artesunate Drugs Business (2019-2024) & (US$ Million)
Table 70. Shin Poong Recent Development
Table 71. Cipla Company Detail
Table 72. Cipla Business Overview
Table 73. Cipla Artesunate Drugs Product
Table 74. Cipla Revenue in Artesunate Drugs Business (2019-2024) & (US$ Million)
Table 75. Cipla Recent Development
Table 76. Acino Company Detail
Table 77. Acino Business Overview
Table 78. Acino Artesunate Drugs Product
Table 79. Acino Revenue in Artesunate Drugs Business (2019-2024) & (US$ Million)
Table 80. Acino Recent Development
Table 81. MCW Healthcare Company Detail
Table 82. MCW Healthcare Business Overview
Table 83. MCW Healthcare Artesunate Drugs Product
Table 84. MCW Healthcare Revenue in Artesunate Drugs Business (2019-2024) & (US$ Million)
Table 85. MCW Healthcare Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artesunate Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Artesunate Drugs Market Share by Type: 2023 VS 2030
Figure 3. Monoaromatic Artesunate Features
Figure 4. Compound Artesunate Features
Figure 5. Global Artesunate Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Artesunate Drugs Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Artesunate Drugs Report Years Considered
Figure 11. Global Artesunate Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Artesunate Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Artesunate Drugs Market Share by Region: 2023 VS 2030
Figure 14. Global Artesunate Drugs Market Share by Players in 2023
Figure 15. Global Top Artesunate Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artesunate Drugs as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Artesunate Drugs Revenue in 2023
Figure 17. North America Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Artesunate Drugs Market Share by Country (2019-2030)
Figure 19. United States Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Artesunate Drugs Market Share by Country (2019-2030)
Figure 23. Germany Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Artesunate Drugs Market Share by Region (2019-2030)
Figure 31. China Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Artesunate Drugs Market Share by Country (2019-2030)
Figure 39. Mexico Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Artesunate Drugs Market Share by Country (2019-2030)
Figure 43. Turkey Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Artesunate Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Fosun Pharma (Guilin) Revenue Growth Rate in Artesunate Drugs Business (2019-2024)
Figure 46. Ipca Laboratories Revenue Growth Rate in Artesunate Drugs Business (2019-2024)
Figure 47. Sanofi Aventis Revenue Growth Rate in Artesunate Drugs Business (2019-2024)
Figure 48. Ajanta Pharma Revenue Growth Rate in Artesunate Drugs Business (2019-2024)
Figure 49. Shin Poong Revenue Growth Rate in Artesunate Drugs Business (2019-2024)
Figure 50. Cipla Revenue Growth Rate in Artesunate Drugs Business (2019-2024)
Figure 51. Acino Revenue Growth Rate in Artesunate Drugs Business (2019-2024)
Figure 52. MCW Healthcare Revenue Growth Rate in Artesunate Drugs Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
